Literature DB >> 6311900

Control of lipopolysaccharide-high density lipoprotein binding by acute phase protein(s).

P S Tobias, R J Ulevitch.   

Abstract

When Salmonella minnesota R595 lipopolysaccharide (LPS) is mixed with serum, the LPS eventually forms a complex with high density lipoprotein (HDL). Complex formation is conveniently followed by CsCl equilibrium density gradient centrifugation. When mixing 10 micrograms LPS with normal rabbit serum (NRS) at 37 degrees C in the presence of 20 mM EDTA, the half-life for LPS binding to HDL is typically 2 to 3 min. When the same experiment is performed with the use of acute phase rabbit serum (APRS; collected 24 hr post-induction with silver nitrate), the half-life for LPS binding to HDL is typically 40 to 100 min. Thus LPS binding to HDL occurs some 20- to 40-fold slower in APRS than in NRS. Two other phenomena have been found, the time dependencies of which correlate well with the time dependency of LPS binding to HDL in APRS. If LPS-APRS reaction mixtures are cooled to 4 degrees C shortly after mixing and are dialyzed against 2.5 mM HEPES, 15 mM NaCl, pH 7.4 buffer, LPS is recovered in the washed precipitates ("euglobulin precipitate") if, and only if, the LPS-HDL binding reaction is not complete. The amount of LPS in the precipitate correlates well with the amount of LPS that has not bound to HDL. The second phenomenon we observe is that the LPS-containing euglobulin precipitate prepared from LPS-acute phase serum reaction mixtures shortly after mixing also contains a protein, gp60, the concentration of which in the euglobulin precipitate correlates well with the amount of LPS in the precipitate. Thus three phenomena are kinetically well correlated in APRS: the degree of binding of LPS to HDL, the degree of appearance of LPS in a euglobulin fraction, and the concentration of protein gp60 in the euglobulin fraction. We were unable to precipitate gp60 from APRS in the absence of LPS, from APRS after the LPS has fully bound to HDL, or from normal serum in the presence or absence of LPS. The known properties of gp60 are not reminiscent of any other known acute phase reactant. These data demonstrate that APRS contains acute phase reactants that interact with LPS to modify its buoyant density, its solubility, and the rate of its binding to HDL.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6311900

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Hepatic uptake and deacylation of the LPS in bloodborne LPS-lipoprotein complexes.

Authors:  Baomei Shao; Robert S Munford; Richard Kitchens; Alan W Varley
Journal:  Innate Immun       Date:  2012-03-22       Impact factor: 2.680

2.  Cytokine response by monocytes and macrophages to free and lipoprotein-bound lipopolysaccharide.

Authors:  J M Cavaillon; C Fitting; N Haeffner-Cavaillon; S J Kirsch; H S Warren
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

3.  Distribution of bacterial endotoxin in human and rabbit blood and effects of stroma-free hemoglobin.

Authors:  R I Roth; F C Levin; J Levin
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

4.  SAA does not induce cytokine production in physiological conditions.

Authors:  Myung-Hee Kim; Maria C de Beer; Joanne M Wroblewski; Nancy R Webb; Frederick C de Beer
Journal:  Cytokine       Date:  2012-11-17       Impact factor: 3.861

5.  The level of lipopolysaccharide-binding protein is significantly increased in plasma in patients with the systemic inflammatory response syndrome.

Authors:  A Myc; J Buck; J Gonin; B Reynolds; U Hammerling; D Emanuel
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

6.  Immunoreactivity and bioactivity of lipopolysaccharide-binding protein in normal and heat-inactivated sera.

Authors:  K Mészáros; S Aberle; M White; J B Parent
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

7.  Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy.

Authors:  P Brandtzaeg; K Bryn; P Kierulf; R Ovstebø; E Namork; B Aase; E Jantzen
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

8.  LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction.

Authors:  A C Vreugdenhil; A M Snoek; C van 't Veer; J W Greve; W A Buurman
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

9.  Control of lipopolysaccharide-high-density lipoprotein interactions by an acute-phase reactant in human serum.

Authors:  P S Tobias; K P McAdam; K Soldau; R J Ulevitch
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

10.  Control of endotoxin activity and interleukin-1 production through regulation of lipopolysaccharide-lipoprotein binding by a macrophage factor.

Authors:  H S Warren; G R Riveau; F A de Deckker; L A Chedid
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.